School of Medicine Homepage
Emory University Shield
  • About
    • Our Vision
    • Academic Departments
    • Our Leadership
    • Health Care Partnerships
    • Diversity, Equity, & Inclusion
    • Location
    • Supporting Our People
    • Our Faculty
    • History
    • News
    • Events
    • Contact Us
  • Education
    • Degree and Certificate Programs
    • Academic Departments
    • Residents & Fellows
    • Postdoctoral Training
    • Continuing Medical Education
    • Admissions
    • Cost and Financial Aid
    • Student Resources
  • Research
    • Research Innovation
    • Conducting Research
    • Core Facilities
    • Research Centers
    • Research Training
    • Academic Departments
    • Find a Researcher
    • Research News
  • Clinical Experience
    • Where We Work
    • Caring for a Diverse Population
    • Faculty Clinical Experience
    • Advanced Patient Care
    • Academic Departments
    • Community Learning
  • Giving
  • Directory

Directory section navigation

  • Faculty Profiles

Emory University School of Medicine

  • About
    • Sub link
      Our Vision
    • Sub link
      Academic Departments
    • Sub link
      Our Leadership
    • Sub link
      Health Care Partnerships
    • Sub link
      Diversity, Equity, & Inclusion
    • Sub link
      Location
    • Sub link
      Supporting Our People
    • Sub link
      Our Faculty
    • Sub link
      History
    • Sub link
      News
    • Sub link
      Events
    • Sub link
      Contact Us
  • Education
    • Sub link
      Degree and Certificate Programs
    • Sub link
      Academic Departments
    • Sub link
      Residents & Fellows
    • Sub link
      Postdoctoral Training
    • Sub link
      Continuing Medical Education
    • Sub link
      Admissions
    • Sub link
      Cost and Financial Aid
    • Sub link
      Student Resources
  • Research
    • Sub link
      Research Innovation
    • Sub link
      Conducting Research
    • Sub link
      Core Facilities
    • Sub link
      Research Centers
    • Sub link
      Research Training
    • Sub link
      Academic Departments
    • Sub link
      Find a Researcher
    • Sub link
      Research News
  • Clinical Experience
    • Sub link
      Where We Work
    • Sub link
      Caring for a Diverse Population
    • Sub link
      Faculty Clinical Experience
    • Sub link
      Advanced Patient Care
    • Sub link
      Academic Departments
    • Sub link
      Community Learning
  • Giving
  • Directory
  • Home School of Medicine Home
  • Directory

Profile

Nicole Schmitt

  • Department of Otolaryngology Head and Neck Surgery
    Associate Professor
  • nicole.cherie.schmitt@emory.edu
Head shot of Nicole Schmitt

Overview

Dr. Nicole Schmitt's clinical and research work is focused on head and neck surgical oncology and novel therapeutic combinations. She received her MD degree at Washington University School of Medicine in 2006. She completed her general surgery internship as well as her research fellowship and residency in otolaryngology head and neck surgery at the University of Washington, and completed a fellowship in head and neck surgery and tumor biology at the University of Pittsburgh.

Prior to joining the Emory Otolaryngology faculty in 2020, Dr. Schmitt was a faculty member at Johns Hopkins University, and a special volunteer and principal investigator for the Integrative Therapeutics Program of the Otolaryngology Surgeon Scientist Program, National Institute on Deafness and Other Communication Disorders, National Institutes of Health.

Academic Appointment

  • Associate Professor, Department of Otolaryngology Head and Neck Surgery, Emory University School of Medicine
  • Co-Director, Translational Research, Head & Neck Program, Winship Cancer Institute

Education

Degrees

  • MD from Washington University School of Medicine, St. Louis

Research

Publications

  • Radiotherapy With Cisplatin vs Carboplatin Paclitaxel for Head and Neck Squamous Cell Carcinoma.
    JAMA Otolaryngol Head Neck Surg
    06/26/2025 Authors: Abousaud M; Pamulapati S; Rashid S; Lozano F; Shepherd M; Fowowe B; Cao Y; Kim P; Liu Y; Bates JE
  • Treatment of recurrent oral carcinoma cuniculatum with immune checkpoint blockade: A case report and literature review.
    Oral Oncol Rep Volume: 14
    06/01/2025 Authors: Jones W; Kaka AS; Rudra S; Lubin D; Saeed F; Magliocca KR; Saba NF; Schmitt NC
  • Reirradiation: Standards, challenges, and patient-focused strategies across tumor types.
    CA Cancer J Clin
    05/29/2025 Authors: Beddok A; Willmann J; Embring A; Appelt AL; Balermpas P; Chua K; Choi JI; Elger BS; Gabrys D; Hoskin P
  • Early-phase trial of IAP antagonist tolinapant and definitive radiation in cisplatin-ineligible patients with advanced head and neck cancer.
    Clin Cancer Res
    05/12/2025 Authors: Schmitt NC; Stokes WA; Bates JE; Kinney BLC; Remick J; McDonald MW; Rudra S; Steininger M; Oyewole M; Patel MR
  • Combination radiation and PD-L1 enhance tumor control by stimulating CD8+PD-1+TCF-1+T cells in the tumor-draining lymph node.
    Nat Commun Volume: 16 Page(s): 3522
    04/14/2025 Authors: Shen Y; Connolly E; Aiello M; Zhou C; Chappa P; Song H; Tippitak P; Clark T; Cardenas M; Prokhnevska N
  • Statin Drugs Are Associated With Response to Immune Checkpoint Blockade in Recurrent/Metastatic Head and Neck Cancer.
    Cancer Med Volume: 14 Page(s): e70718
    03/01/2025 Authors: Kristoff TJ; Evans S; Nayi P; Abousaud M; Goyal S; Liu Y; Shin D; Steuer CE; Saba NF; Schmitt NC
  • Radiologic findings of occult nodal metastasis during clinically-N0 salvage total laryngectomy.
    Head Neck Volume: 47 Page(s): 201 - 214
    01/01/2025 Authors: Chan TG; Wicks J; Sethi I; Becker J; Brandon D; Schmitt NC; Kaka A; Boyce B; Baddour HM; El-Deiry MW
  • Age and postoperative swallowing function in patients treated for advanced oral cancer: A retrospective study.
    J Geriatr Oncol Volume: 15 Page(s): 101841
    11/01/2024 Authors: Amos SE; Daoud GE; Patel SR; Burnham AJ; Ottenstein L; Baddour HM; Tkaczuk A; Schmitt NC
  • Pembrolizumab and Cabozantinib in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Long-term Survival Update with a Biomarker Analysis.
    Clin Cancer Res Volume: 30 Page(s): 4601 - 4608
    10/15/2024 Authors: Saba NF; Chaudhary R; Kirtane K; Marra A; Ekpenyong A; McCook-Veal A; Schmitt NC; Gross JH; Patel MR; Remick J
  • Assessing survival outcomes of patients with oral tongue squamous cell carcinoma: Focus on age, sex, and stage.
    Head Neck Volume: 46 Page(s): 2167 - 2177
    09/01/2024 Authors: Pamulapati S; Abousaud M; Li Y; Ekpenyong A; Rudra S; Remick JS; Bates JE; Stokes WA; McDonald MW; Schmitt NC
  • Strategies for Improving CAR T Cell Persistence in Solid Tumors.
    Cancers (Basel) Volume: 16
    08/16/2024 Authors: Wittling MC; Cole AC; Brammer B; Diatikar KG; Schmitt NC; Paulos CM
  • Author Correction: Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial.
    Nat Med Volume: 30 Page(s): 2373
    08/01/2024 Authors: Saba NF; Steuer CE; Ekpenyong A; McCook-Veal A; Magliocca K; Patel M; Schmitt NC; Stokes W; Bates JE; Rudra S
  • Intensity-Modulated Reirradiation Therapy With Nivolumab in Recurrent or Second Primary Head and Neck Squamous Cell Carcinoma: A Nonrandomized Controlled Trial.
    JAMA Oncol Volume: 10 Page(s): 896 - 904
    07/01/2024 Authors: Saba NF; Wong SJ; Nasti T; McCook-Veal AA; McDonald MW; Stokes WA; Anderson AM; Ekpenyong A; Rupji M; Abousaud M
  • Characterization of the tumor microenvironment in the mouse oral cancer (MOC1) model after orthotopic implantation in the buccal mucosa.
    Head Neck Volume: 46 Page(s): 1056 - 1062
    05/01/2024 Authors: Kansal V; Kinney BLC; Schmitt NC
  • Combined IL6 and CCR2 blockade potentiates antitumor activity of NK cells in HPV-negative head and neck cancer.
    J Exp Clin Cancer Res Volume: 43 Page(s): 76
    03/12/2024 Authors: Yang F; Yuan C; Chen F; Qin ZS; Schmitt NC; Lesinski GB; Saba NF; Teng Y
  • Radiation and anti-PD-L1 synergize by stimulating a stem-like T cell population in the tumor-draining lymph node.
    Res Sq
    03/06/2024 Authors: Shen Y; Connolly E; Aiello M; Zhou C; Chappa P; Song H; Tippitak P; Clark T; Cardenas M; Prokhnevska N
  • Oncologic Safety of Close Margins in Patients With Low- to Intermediate-Grade Major Salivary Gland Carcinoma.
    JAMA Otolaryngol Head Neck Surg Volume: 150 Page(s): 107 - 116
    02/01/2024 Authors: Sajisevi M; Nguyen K; Callas P; Holcomb AJ; Vural E; Davis KP; Thomas CM; Plonowska-Hirschfeld KA; Stein JS; Eskander A
  • Rescue of NLRC5 expression restores antigen processing machinery in head and neck cancer cells lacking functional STAT1 and p53.
    Cancer Immunol Immunother Volume: 73 Page(s): 10
    01/17/2024 Authors: Kinney BLC; Gunti S; Kansal V; Parrish CJ; Saba NF; Teng Y; Henry MK; Su F-Y; Kwong GA; Schmitt NC
  • Orthotopic injection of an established syngeneic mouse oral cancer cell line (MOC1) induces a robust draining lymph node response.
    bioRxiv
    01/14/2024 Authors: Kansal V; Kinney BLC; Schmitt NC
  • CD28-CD57+ T cells from head and neck cancer patients produce high levels of cytotoxic granules and type II interferon but are not senescent.
    Oncoimmunology Volume: 13 Page(s): 2367777
    01/01/2024 Authors: Kinney BLC; Brammer B; Kansal V; Parrish CJ; Kissick HT; Liu Y; Saba NF; Buchwald ZS; El-Deiry MW; Patel MR
  • Submental Island Flaps for Lateral Reconstruction: Technical Refinements for Optimal Outcomes and Resource Efficiency.
    OTO Open Volume: 8 Page(s): e131
    01/01/2024 Authors: Oh MS; Vettikattu NT; Baddour HM; Gross JH; Boyce BJ; Patel MR; Schmitt NC; Arturo Solares C; Vuncannon JR; Kaka AS
  • Effects of socioeconomic status on enrollment in clinical trials for cancer: A systematic review.
    Cancer Med Volume: 13 Page(s): e6905
    01/01/2024 Authors: Donzo MW; Nguyen G; Nemeth JK; Owoc MS; Mady LJ; Chen AY; Schmitt NC
  • Long-Term Follow-up of Parenteral Bevacizumab In Patients with Recurrent Respiratory Papillomatosis.
    Laryngoscope Volume: 133 Page(s): 2725 - 2733
    10/01/2023 Authors: Ballestas SA; Hidalgo Lopez J; Klein AM; Steuer C; Shin DM; Abousaud M; Schmitt NC; Teng Y; Saba NF; Tkaczuk AT
  • Quality of life and decisional regret after total glossectomy with laryngectomy: A single-institution case series.
    Oral Oncol Volume: 142 Page(s): 106434
    07/01/2023 Authors: Amechi C; Ottenstein L; Lang A; McClary T; Avinger AM; Burnham AJ; Dixon MD; Pentz RD; Schmitt NC
  • The expanding role of IAP antagonists for the treatment of head and neck cancer.
    Cancer Med Volume: 12 Page(s): 13958 - 13965
    07/01/2023 Authors: Kansal V; Kinney BLC; Uppada S; Saba NF; Stokes WA; Buchwald ZS; Schmitt NC
  • Laryngeal Anatomy, Molecular Biology, Cause, and Risk Factors for Laryngeal Cancer.
    Otolaryngol Clin North Am Volume: 56 Page(s): 197 - 203
    04/01/2023 Authors: Law AB; Schmitt NC
  • Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial.
    Nat Med Volume: 29 Page(s): 880 - 887
    04/01/2023 Authors: Saba NF; Steuer CE; Ekpenyong A; McCook-Veal A; Magliocca K; Patel M; Schmitt NC; Stokes W; Bates JE; Rudra S
  • Role of HER2 in Prognosis of Salivary Duct Carcinoma: A Systematic Review and Meta-Analysis.
    Laryngoscope Volume: 133 Page(s): 476 - 484
    03/01/2023 Authors: Williams CYK; Townson AT; Terry N; Schmitt NC; Sharma A
  • Survival and functional outcomes after total glossectomy with total laryngectomy: Case series from a high-volume tertiary institution.
    Oral Oncol Volume: 137 Page(s): 106301
    02/01/2023 Authors: Burnham AJ; Boyce BJ; Kaka AS; El-Deiry MW; Sebelik ME; Baddour HM; Patel MR; Gross JH; Nathan M; Waller JM
  • Specimen-Based Resection Margins and Local Control during Transoral Robotic Surgery for Oropharyngeal HPV-Mediated Squamous Cell Carcinoma.
    ORL J Otorhinolaryngol Relat Spec Volume: 85 Page(s): 80 - 87
    01/01/2023 Authors: Magliocca KR; Kaka AS; Barrow EM; Studer MB; Griffith CC; Ernst J; Meade T; Balicki A; Boyce BJ; Schmitt NC
  • Statin drugs enhance responses to immune checkpoint blockade in head and neck cancer models.
    J Immunother Cancer Volume: 11
    01/01/2023 Authors: Kansal V; Burnham AJ; Kinney BLC; Saba NF; Paulos C; Lesinski GB; Buchwald ZS; Schmitt NC
  • Free Flap Fat Volume is Not Associated With Recurrence or Wound Complications in Oral Cancer.
    OTO Open Volume: 7 Page(s): e46
    01/01/2023 Authors: Burnham AJ; Wicks J; Baugnon KL; El-Deiry MW; Schmitt NC
  • The evolving landscape of salivary gland tumors.
    CA Cancer J Clin Volume: 73 Page(s): 597 - 619
    01/01/2023 Authors: Steuer CE; Hanna GJ; Viswanathan K; Bates JE; Kaka AS; Schmitt NC; Ho AL; Saba NF
  • Critical review of the current and future prospects of VEGF-TKIs in the management of squamous cell carcinoma of head and neck.
    Front Oncol Volume: 13 Page(s): 1310106
    01/01/2023 Authors: Puttagunta P; Pamulapati SV; Bates JE; Gross JH; Stokes WA; Schmitt NC; Steuer C; Teng Y; Saba NF
  • ASO Visual Abstract: Team-Based Surgical Scheduling for Improved Patient Access in a High-Volume, Tertiary Head and Neck Cancer Center.
    Ann Surg Oncol Volume: 29 Page(s): 7007 - 7008
    10/01/2022 Authors: Schmitt NC; Ryan M; Halle T; Sherrod A; Wadsworth JT; Patel MR; El-Deiry MW
  • Team-Based Surgical Scheduling for Improved Patient Access in a High-Volume, Tertiary Head and Neck Cancer Center.
    Ann Surg Oncol Volume: 29 Page(s): 7002 - 7006
    10/01/2022 Authors: Schmitt NC; Ryan M; Halle T; Sherrod A; Wadsworth JT; Patel MR; El-Deiry MW
  • Institutional Comparison between Radiation with Concurrent Cisplatin Versus Carboplatin/paclitaxel for Squamous Cell Carcinoma of the Head and Neck (SCCHN)
    Volume: 112 Page(s): E12 - E13
    04/01/2022 Authors: Abousaud M; Shepherd M; Lozano F; Fowowe B; Cao Y; Rudra S; Stokes WA; Schmitt NC; El-Deiry MW; Patel MR
  • Oropharyngeal HPV-Mediated Squamous Cell Carcinoma, Basaloid-type (SOX10+): A Variant To Be Highlighted In Our Diagnostic Terminology?
    Volume: 35 Page(s): 864 - 865
    03/01/2022 Authors: Broder K; Saeed F; Lubin D; (Judy) Shi Q; Viswanathan K; Patel M; Schmitt N; Magliocca K
  • Oropharyngeal HPV-Mediated Squamous Cell Carcinoma, Basaloid-type (SOX10+): A Variant To Be Highlighted In Our Diagnostic Terminology?
    Volume: 102 Page(s): 864 - 865
    03/01/2022 Authors: Broder K; Saeed F; Lubin D; (Judy) Shi Q; Viswanathan K; Patel M; Schmitt N; Magliocca K
  • Survival, functional, and quality of life outcomes between total glossectomy with and without total laryngectomy: A narrative review.
    Am J Otolaryngol Volume: 43 Page(s): 103440
    01/01/2022 Authors: Burnham AJ; Ottenstein L; Boyce BJ; Kaka AS; El-Deiry MW; Baddour HM; Patel MR; Gross JH; Schmitt NC
  • The Role of HPV in Cancer Prognosis-Location, Location, Location.
    JAMA Otolaryngol Head Neck Surg Volume: 148 Page(s): 79 - 80
    01/01/2022 Authors: Schmitt NC
  • CA209-9KY: Phase II Study of IMRT Re-Irradiation and Concurrent/Adjuvant Nivolumab (Nivo) in Patients With Loco Regionally Recurrent or Second Primary Head and Neck Squamous Cell Carcinoma (HNSCC) - Toxicity and Quality of Life (QoL) Results
    Volume: 111 Page(s): E361 - E361
    11/01/2021 Authors: Saba NF; Wong S; Stokes WA; Rupji M; Liu Y; Rudra S; Bates JE; Steuer C; Remick JS; Cummings K
  • CA209-9KY: Phase II Study of IMRT Re-Irradiation and Concurrent/Adjuvant Nivolumab (Nivo) in Patients With Loco Regionally Recurrent or Second Primary Head and Neck Squamous Cell Carcinoma (HNSCC) - Toxicity and Quality of Life (QoL) Results.
    Int J Radiat Oncol Biol Phys Volume: 111 Page(s): e361
    11/01/2021 Authors: Saba NF; Wong S; Stokes WA; Rupji M; Liu Y; Rudra S; Bates JE; Steuer C; Remick JS; Cummings K
  • Biologics in Otolaryngology: Triumphs, Challenges, and New Possibilities.
    Otolaryngol Clin North Am Volume: 54 Page(s): xv - xvi
    08/01/2021 Authors: Schmitt NC; Wise SK; Monfared A
  • Biologics in Otolaryngology: Past, Present, and Future.
    Otolaryngol Clin North Am Volume: 54 Page(s): 675 - 687
    08/01/2021 Authors: Schmitt NC; Monfared A; Wise SK
  • Immunotherapeutic Strategies for Head and Neck Cancer.
    Otolaryngol Clin North Am Volume: 54 Page(s): 729 - 742
    08/01/2021 Authors: Buchwald ZS; Schmitt NC
  • The role of age in treatment decisions for oral cavity squamous cell carcinoma: Analysis of the National Cancer Database.
    Oral Oncol Volume: 118 Page(s): 105330
    07/01/2021 Authors: Barrett TF; Mazul AL; Stepan KO; Wood CB; Paniello RC; Zevallos JP; Massa S; Jackson RS; Schmitt NC; Zenga J
  • Atorvastatin is associated with reduced cisplatin-induced hearing loss.
    J Clin Invest Volume: 131
    01/04/2021 Authors: Fernandez KA; Allen P; Campbell M; Page B; Townes T; Li C-M; Cheng H; Garrett J; Mulquin M; Clements A
  • Repurposing Statin Drugs to Decrease Toxicity and Improve Survival Outcomes in Head and Neck Cancer.
    OTO Open Volume: 5 Page(s): 2473974X211065715
    01/01/2021 Authors: Bourguillon RO; Stokes WA; Dorth J; Schmitt NC
  • Feasibility of Portable Audiometry for Ototoxicity Monitoring in a Radiation Oncology Clinic for Head and Neck Cancer Patients Receiving Cisplatin-Based Chemoradiotherapy
    Volume: 108 Page(s): E802 - E802
    11/01/2020 Authors: Page BR; Fernandez K; Garrett J; Marcia M; Clements A; Schmitt NC; Cunningham LL
  • HPV in non-oropharyngeal head and neck cancer: does it matter?
    Ann Transl Med Volume: 8 Page(s): 1120
    09/01/2020 Authors: Schmitt NC
  • Antagonist of cIAP1/2 and XIAP induces immunogenic cell death and alters antigen-processing machinery in preclinical head and neck cancer models
    Volume: 26 Page(s): 56 - 57
    06/01/2020 Authors: Ye W; Gunti S; Van Waes C; Schmitt NC
  • Inhibition of MDSC Trafficking with SX-682, a CXCR1/2 Inhibitor, Enhances NK-Cell Immunotherapy in Head and Neck Cancer Models.
    Clin Cancer Res Volume: 26 Page(s): 1420 - 1431
    03/15/2020 Authors: Greene S; Robbins Y; Mydlarz WK; Huynh AP; Schmitt NC; Friedman J; Horn LA; Palena C; Schlom J; Maeda DY
  • Neoadjuvant PD-1 Immune Checkpoint Blockade Reverses Functional Immunodominance among Tumor Antigen-Specific T Cells.
    Clin Cancer Res Volume: 26 Page(s): 679 - 689
    02/01/2020 Authors: Friedman J; Moore EC; Zolkind P; Robbins Y; Clavijo PE; Sun L; Greene S; Morisada MV; Mydlarz WK; Schmitt N
  • ASTX660, an antagonist of cIAP1/2 and XIAP, increases antigen processing machinery and can enhance radiation-induced immunogenic cell death in preclinical models of head and neck cancer.
    Oncoimmunology Volume: 9 Page(s): 1710398
    01/01/2020 Authors: Ye W; Gunti S; Allen CT; Hong Y; Clavijo PE; Van Waes C; Schmitt NC
  • Dual Antagonist of cIAP/XIAP ASTX660 Sensitizes HPV- and HPV+ Head and Neck Cancers to TNF, TRAIL, and Radiation Therapy.
    Clin Cancer Res Volume: 25 Page(s): 6463 - 6474
    11/01/2019 Authors: Xiao R; An Y; Ye W; Derakhshan A; Cheng H; Yang X; Allen C; Chen Z; Schmitt NC; Van Waes C
  • Definitive Management of Early Stage Oropharyngeal Carcinoma: A Comparison of Long Term Outcomes Following Transoral Surgery or Definitive Chemoradiation
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS Volume: 105 Page(s): E414 - E414
    09/01/2019 Authors: Deek MP; Cecil E; Sloan L; Cheng Z; Han P; Sheikh K; Gui C; Guo Y; Lakshminarayanan P; Fakhry C
  • Cisplatin and oxaliplatin induce similar immunogenic changes in preclinical models of head and neck cancer.
    Oral Oncol Volume: 95 Page(s): 127 - 135
    08/01/2019 Authors: Park S-J; Ye W; Xiao R; Silvin C; Padget M; Hodge JW; Van Waes C; Schmitt NC
  • Pembrolizumab for recurrent/metastatic head and neck cancer: equally promising for Asian patients?
    Ann Transl Med Volume: 7 Page(s): S14
    03/01/2019 Authors: Ye W; Schmitt NC
  • Exceptional responses to pertuzumab, trastuzumab, and docetaxel in human epidermal growth factor receptor-2 high expressing salivary duct carcinomas.
    Head Neck Volume: 40 Page(s): E100 - E106
    12/01/2018 Authors: Park JC; Ma TM; Rooper L; Hembrough T; Foss RD; Schmitt NC; Sawhney R; Flanders A; Kang H
  • Radiation-Associated Sarcoma of the Neck: Case Series and Systematic Review.
    Ann Otol Rhinol Laryngol Volume: 127 Page(s): 735 - 740
    10/01/2018 Authors: Williams L; Tmanova L; Mydlarz WK; Page B; Richmon JD; Quon H; Schmitt NC
  • Chemoradiation-induced hearing loss remains a major concern for head and neck cancer patients.
    Int J Audiol Volume: 57 Page(s): S49 - S54
    09/01/2018 Authors: Schmitt NC; Page BR
  • PD-1 Inhibition Minimally Affects Cisplatin-Induced Toxicities in a Murine Model.
    Otolaryngol Head Neck Surg Volume: 159 Page(s): 343 - 346
    08/01/2018 Authors: Spielbauer K; Cunningham L; Schmitt N
  • Planned Observational Study of Hearing Loss and the Effects of Statin Drugs in Head and Neck Squamous Cell Carcinoma Patients Treated With Chemoradiation
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS Volume: 100 Page(s): 1405 - 1405
    04/01/2018 Authors: Schmitt NC; Fernandez K; Page BR; Cunningham LL
  • T cell receptor richness in peripheral blood increases after cetuximab therapy and correlates with therapeutic response.
    Oncoimmunology Volume: 7 Page(s): e1494112
    01/01/2018 Authors: Kansy BA; Shayan G; Jie H-B; Gibson SP; Lei YL; Brandau S; Lang S; Schmitt NC; Ding F; Lin Y
  • Antagonist of cIAP1/2 and XIAP enhances anti-tumor immunity when combined with radiation and PD-1 blockade in a syngeneic model of head and neck cancer.
    Oncoimmunology Volume: 7 Page(s): e1471440
    01/01/2018 Authors: Xiao R; Allen CT; Tran L; Patel P; Park S-J; Chen Z; Van Waes C; Schmitt NC
  • Cisplatin Alters Antitumor Immunity and Synergizes with PD-1/PD-L1 Inhibition in Head and Neck Squamous Cell Carcinoma.
    Cancer Immunol Res Volume: 5 Page(s): 1141 - 1151
    12/01/2017 Authors: Tran L; Allen CT; Xiao R; Moore E; Davis R; Park S-J; Spielbauer K; Van Waes C; Schmitt NC
  • PD-1 Status in CD8+ T Cells Associates with Survival and Anti-PD-1 Therapeutic Outcomes in Head and Neck Cancer.
    Cancer Res Volume: 77 Page(s): 6353 - 6364
    11/15/2017 Authors: Kansy BA; Concha-Benavente F; Srivastava RM; Jie H-B; Shayan G; Lei Y; Moskovitz J; Moy J; Li J; Brandau S
  • Human papillomavirus 16 E6 antibodies are sensitive for human papillomavirus-driven oropharyngeal cancer and are associated with recurrence.
    Cancer Volume: 123 Page(s): 4382 - 4390
    11/15/2017 Authors: Lang Kuhs KA; Kreimer AR; Trivedi S; Holzinger D; Pawlita M; Pfeiffer RM; Gibson SP; Schmitt NC; Hildesheim A; Waterboer T
  • Dual cIAP1/XIAP inhibitor ASTX660 synergizes with radiation therapy and PD-1 blockade to enhance anti-tumor immunity
    JOURNAL FOR IMMUNOTHERAPY OF CANCER Volume: 5
    11/07/2017 Authors: Xiao R; Allen C; Tran L; Park S-J; Chen Z; Van Waes C; Schmitt N
  • Cisplatin induces immunogenic cell death in preclinical models of head and neck squamous cell carcinoma
    JOURNAL FOR IMMUNOTHERAPY OF CANCER Volume: 5
    11/07/2017 Authors: Park S-J; Tran L; Xiao R; Van Waes C; Schmitt N
  • Salivary duct carcinoma: An aggressive salivary gland malignancy with opportunities for targeted therapy.
    Oral Oncol Volume: 74 Page(s): 40 - 48
    11/01/2017 Authors: Schmitt NC; Kang H; Sharma A
  • Putting T cells to work-outsourcing neoantigen detection in head and neck cancers?
    Oral Dis Volume: 23 Page(s): 820 - 821
    10/01/2017 Authors: Xiao R; Van Waes C; Schmitt NC
  • Adaptive resistance to anti-PD1 therapy by Tim-3 upregulation is mediated by the PI3K-Akt pathway in head and neck cancer.
    Oncoimmunology Volume: 6 Page(s): e1261779
    01/01/2017 Authors: Shayan G; Srivastava R; Li J; Schmitt N; Kane LP; Ferris RL
  • Phase II trial of post-operative radiotherapy with concurrent cisplatin plus panitumumab in patients with high-risk, resected head and neck cancer.
    Ann Oncol Volume: 27 Page(s): 2257 - 2262
    12/01/2016 Authors: Ferris RL; Geiger JL; Trivedi S; Schmitt NC; Heron DE; Johnson JT; Kim S; Duvvuri U; Clump DA; Bauman JE
  • Cervical Osteomyelitis After Pharyngeal Surgical Manipulation.
    JAMA Otolaryngol Head Neck Surg Volume: 142 Page(s): 1130
    11/01/2016 Authors: Govil N; Schmitt NC; Kim S
  • Characterization of human papillomavirus antibodies in individuals with head and neck cancer.
    Cancer Epidemiol Volume: 42 Page(s): 46 - 52
    06/01/2016 Authors: Lang Kuhs KA; Pawlita M; Gibson SP; Schmitt NC; Trivedi S; Argiris A; Kreimer AR; Ferris RL; Waterboer T
  • A 20-Year Review of 75 Cases of Salivary Duct Carcinoma.
    JAMA Otolaryngol Head Neck Surg Volume: 142 Page(s): 489 - 495
    05/01/2016 Authors: Gilbert MR; Sharma A; Schmitt NC; Johnson JT; Ferris RL; Duvvuri U; Kim S
  • Early T Stage Salivary Duct Carcinoma: Outcomes and Implications
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS Volume: 94 Page(s): 954 - 954
    03/15/2016 Authors: Sharma A; Schmitt NC; Gilbert MR; Kim S
  • Costimulatory and coinhibitory immune checkpoint receptors in head and neck cancer: unleashing immune responses through therapeutic combinations.
    Cancers Head Neck Volume: 1 Page(s): 12
    01/01/2016 Authors: Davis RJ; Ferris RL; Schmitt NC
  • Tumor-infiltrating Tim-3+ T cells proliferate avidly except when PD-1 is co-expressed: Evidence for intracellular cross talk.
    Oncoimmunology Volume: 5 Page(s): e1200778
    01/01/2016 Authors: Li J; Shayan G; Avery L; Jie H-B; Gildener-Leapman N; Schmitt N; Lu BF; Kane LP; Ferris RL
  • Intraoperative identification of the human communicating nerve during thyroidectomy.
    J Surg Case Rep Volume: 2015
    12/13/2015 Authors: Hodnett BL; Schmitt NC; Thirumala PD; Duvvuri U
  • Antibiotic Prophylaxis in Patients Undergoing Head and Neck Free Flap Reconstruction.
    JAMA Otolaryngol Head Neck Surg Volume: 141 Page(s): 1096 - 1103
    12/01/2015 Authors: Mitchell RM; Mendez E; Schmitt NC; Bhrany AD; Futran ND
  • Early T Stage Salivary Duct Carcinoma: Outcomes and Implications for Patient Counseling.
    Otolaryngol Head Neck Surg Volume: 153 Page(s): 795 - 798
    11/01/2015 Authors: Schmitt NC; Sharma A; Gilbert MR; Kim S
  • STAT1 Activation Is Enhanced by Cisplatin and Variably Affected by EGFR Inhibition in HNSCC Cells.
    Mol Cancer Ther Volume: 14 Page(s): 2103 - 2111
    09/01/2015 Authors: Schmitt NC; Trivedi S; Ferris RL
  • Superior laryngeal nerve monitoring using laryngeal surface electrodes and intraoperative neurophysiological monitoring during thyroidectomy.
    Clin Anat Volume: 28 Page(s): 460 - 466
    05/01/2015 Authors: Hodnett BL; Schmitt NC; Clayburgh DR; Burkowsky A; Balzer J; Thirumala PD; Duvvuri U
  • Transoral robotic surgery for oropharyngeal squamous cell carcinoma.
    Curr Opin Otolaryngol Head Neck Surg Volume: 23 Page(s): 127 - 131
    04/01/2015 Authors: Schmitt NC; Duvvuri U
  • Immune biomarkers of anti-EGFR monoclonal antibody therapy.
    Ann Oncol Volume: 26 Page(s): 40 - 47
    01/01/2015 Authors: Trivedi S; Concha-Benavente F; Srivastava RM; Jie HB; Gibson SP; Schmitt NC; Ferris RL
  • Phase II trial of radiotherapy (RT) with concurrent cisplatin (C) plus panitumumab (pmAb) for patients (pts) with high-risk, resected head and neck cancer (HNC).
    JOURNAL OF CLINICAL ONCOLOGY Volume: 32
    05/20/2014 Authors: Ferris RL; Schmitt NC; Heron DE; Johnson JT; Kim S; Duvvuri U; Clump DA; Grandis J; Bauman JE; Gooding WE
  • Osteopontin does not mitigate cisplatin ototoxicity or nephrotoxicity in adult mice.
    Otolaryngol Head Neck Surg Volume: 149 Page(s): 614 - 620
    10/01/2013 Authors: Schmitt NC; Rubel EW
  • Pathology quiz case 1. Diagnosis: laryngeal rhabdomyosarcoma, embryonal subtype.
    Arch Otolaryngol Head Neck Surg Volume: 137 Page(s): 635 - 639
    06/01/2011 Authors: Hsia JC; Schmitt NC; Hoch B; Moe KS
  • Head and neck cancers.
    Volume: 9 Page(s): 596 - 650
    06/01/2011 Authors: Pfister DG; Ang K-K; Brizel DM; Burtness BA; Cmelak AJ; Colevas AD; Dunphy F; Eisele DW; Gilbert J; Gillison ML
  • Cisplatin-induced hair cell death requires STAT1 and is attenuated by epigallocatechin gallate.
    J Neurosci Volume: 29 Page(s): 3843 - 3851
    03/25/2009 Authors: Schmitt NC; Rubel EW; Nathanson NM
  • Fine-Needle Aspiration of Neck Masses

    Authors: Schmitt NC; Johnson JT
Read more publications Fewer publications
Directory
  • Faculty Profiles
Emory University Homepage

Contact & Location

Emory University School of Medicine
100 Woodruff Circle
Atlanta, GA  30322 USA
  • Contact Us
  • Maps & Directions
  • Careers

Information For

  • Alumni
  • Faculty & Staff
  • Patients
  • Residents & Fellows
  • Students
Support the School of Medicine School of Medicine Intranet
facebook facebook twitter twitter linkedin linkedin instagram instagram youtube youtube
© 2025 Emory University
  • Privacy Policy
  • Emergency Information
  • EEO Employer-Disability/Veteran Statements